Who owns Harvard Bioscience?
- Ticker: HBIO
- CUSIP Number: 416906105
Tip: Access positions for across all investors
Analyze quarterly positions in Harvard Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Harvard Bioscience stock
Who bought or sold Harvard Bioscience this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AMH Equity | 4.0M | $1.8M | 15% | Sep 2025 |
|
| Weber Capital Management | 3.2M | $2.1M | 100% | Dec 2025 |
|
| Harvey Partners | 2.1M | $899k | -4% | Sep 2025 |
|
| Vanguard Group | 1.9M | $1.3M | 4% | Dec 2025 |
|
| Acadian Asset Management | 1.8M | $1.2M | 66% | Dec 2025 |
|
| Meros Investment Management | 1.2M | $814k | 33% | Dec 2025 |
|
| Renaissance Technologies | 1.0M | $683k | 18% | Dec 2025 |
|
| BlackRock | 622k | $416k | 0% | Dec 2025 |
|
| Granahan Investment Management | 604k | $265k | -60% | Sep 2025 |
|
| Nano Cap New Millennium Growth Fund | 600k | $401k | 100% | Dec 2025 |
|
| Millennium Management | 572k | $251k | -11% | Sep 2025 |
|
| Two Sigma Investments | 474k | $208k | 140% | Sep 2025 |
|
| Geode Capital Management | 461k | $308k | 4% | Dec 2025 |
|
| Jane Street | 445k | $298k | 997% | Dec 2025 |
|
| Williams & Novak | 349k | $233k | 27% | Dec 2025 |
|
| Two Sigma Advisers | 243k | $107k | 419% | Sep 2025 |
|
| Essex Investment Management | 185k | $124k | 100% | Dec 2025 |
|
| Rbf Capital | 160k | $70k | 0% | Sep 2025 |
|
| State Street Corporation | 149k | $100k | 0% | Dec 2025 |
|
| Susquehanna International | 140k | $94k | 66% | Dec 2025 |
|
| Assenagon Asset Management | 139k | $93k | 0% | Dec 2025 |
|
| Bank of New York Mellon | 126k | $84k | 0% | Dec 2025 |
|
| Corsair Capital Management | 100k | $44k | 100% | Sep 2025 |
|
| Northern Trust | 92k | $62k | -37% | Dec 2025 |
|
| Virtu Financial | 60k | $40k | 100% | Dec 2025 |
|
| GAMCO Asset Management | 57k | $38k | 100% | Dec 2025 |
|
| Goldman Sachs Group | 50k | $33k | 292% | Dec 2025 |
|
| FMR | 46k | $20k | -37% | Sep 2025 |
|
| Pasadena Private Wealth | 45k | $30k | -82% | Dec 2025 |
|
| Legato Capital Management | 44k | $29k | 210% | Dec 2025 |
|
| Citadel Advisors | 42k | $19k | -54% | Sep 2025 |
|
| XTX Topco | 39k | $26k | 100% | Dec 2025 |
|
| Gabelli Funds | 39k | $26k | 0% | Dec 2025 |
|
| Callan Family Office | 30k | $20k | 0% | Dec 2025 |
|
| Dimensional Fund Advisors | 28k | $19k | -94% | Dec 2025 |
|
| Greenwood Capital Associates | 28k | $19k | 0% | Dec 2025 |
|
| Group One Trading | 26k | $17k | 1307% | Dec 2025 |
|
| Abel Hall | 25k | $17k | -21% | Dec 2025 |
|
| UBS Group | 21k | $14k | 60% | Dec 2025 |
|
| Two Sigma Securities | 18k | $12k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 17k | $11k | -54% | Dec 2025 |
|
| JustInvest | 17k | $11k | 100% | Dec 2025 |
|
| Point72 Asset Management | 15k | $9.8k | 100% | Dec 2025 |
|
| Point72 Asia | 15k | $6.4k | -46% | Sep 2025 |
|
| Simplex Trading | 14k | $9.2k | 402% | Dec 2025 |
|
| Camden Capital | 14k | $9.1k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 13k | $5.5k | 0% | Sep 2025 |
|
| Wolverine Trading | 12k | $5.1k | -64% | Sep 2025 |
|
| Ethic | 11k | $7.3k | -12% | Dec 2025 |
|
| Balboa Wealth Partners | 10k | $6.7k | -15% | Dec 2025 |
|
| SBI Securities | 8.7k | $5.8k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 7.4k | $0 | 4617% | Sep 2025 |
|
| Brown Shipley& Co | 4.8k | $3.2k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.4k | $1.6k | -72% | Dec 2025 |
|
| NISA Investment Advisors | 2.3k | $1.5k | 0% | Dec 2025 |
|
| Federated Investors | 1.7k | $1.1k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.6k | $717.988200 | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 680.00 | $454.988000 | 0% | Dec 2025 |
|
| Financial Connections Group | 300.00 | $0 | 0% | Dec 2025 |
|
| Pnc Financial Services | 144.00 | $96.004800 | -98% | Dec 2025 |
|
| CWM | 54.00 | $0 | -26% | Dec 2025 |
|
| Barclays | 21.00 | $14.000700 | 2000% | Dec 2025 |
|
| Optiver Holding B.V. | 14.00 | $9.000600 | 0% | Dec 2025 |
|
Who sold out of Harvard Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Acuitas Investments | Sep 2025 | 491k | $215k |
| AQR Capital Management | Jun 2025 | 46k | $20k |
| Brighton Jones | Sep 2025 | 25k | $11k |
| Northwestern Mutual Wealth Management Company | Sep 2025 | 1.9k | $832.960000 |
| EverSource Wealth Advisors | Sep 2025 | 1.2k | $535.019100 |
| Rialto Wealth Management | Sep 2025 | 1.1k | $474.991400 |